AtriCure market cap is $1.7 b, and annual revenue was $230.81 m in FY 2019

AtriCure Gross profit (Q2, 2020)27.7 M

AtriCure Gross profit margin (Q2, 2020), %67.7%

AtriCure Net income (Q2, 2020)-8.2 M

AtriCure EBIT (Q2, 2020)-7.3 M

AtriCure Cash, 30-Jun-202088.5 M

AtriCure EV1.7 B

AtriCure revenue was $230.81 m in FY, 2019

USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 64.4m | 70.2m | 81.9m | 107.5m | 129.8m | 155.1m | 174.7m | 201.6m | 230.8m |

| 31% | 21% | 20% | ||||||

## Cost of goods sold | 17.4m | 20.2m | 22.3m | 31.7m | 36.9m | 44.0m | 48.6m | 785.0k | 635.0k |

## Gross profit | 47.0m | 50.0m | 59.6m | 75.8m | 92.9m | 111.1m | 126.2m | 200.8m | 230.2m |

| 73% | 71% | 73% | 70% | 72% | 72% | 72% | 100% | 100% |

## R&D expense | 11.9m | 12.1m | 13.4m | 18.6m | 25.7m | 35.8m | 34.1m | 34.7m | 41.2m |

## General and administrative expense | 39.9m | 45.1m | 57.0m | 73.5m | 93.9m | 106.4m | 117.0m | 129.5m | 162.2m |

## Operating expense total | 51.7m | 57.2m | 48.7m | 92.1m | 119.6m | 142.2m | 151.1m | 164.2m | 203.5m |

## EBIT | (4.7m) | (7.2m) | 10.9m | (16.4m) | (26.7m) | (31.1m) | (25.0m) | (17.1m) | (33.1m) |

| (7%) | (10%) | 13% | (15%) | (21%) | (20%) | (14%) | (8%) | (14%) |

## Interest expense | 814.4k | 802.0k | 115.0k | ||||||

## Interest income | 15.9k | 11.0k | 16.0k | 96.0k | 190.0k | 227.0k | 227.0k | 1.0m | 2.4m |

## Pre tax profit | (5.4m) | (7.5m) | (11.4m) | (16.2m) | (27.2m) | (33.3m) | (26.9m) | (20.9m) | (35.0m) |

## Income tax expense | 30.9k | 50.0k | 18.0k | 33.0k | 36.0k | 40.0k | 14.0k | 226.0k | 199.0k |

## Net Income | (5.5m) | (7.5m) | (11.5m) | (16.2m) | (27.2m) | (33.3m) | (26.9m) | (21.1m) | (35.2m) |

USD | Q2, 2011 |
---|---|

## Financial Leverage | 2.1 x |